MedTrace Logo

Use of Magnetocardiography in Evaluation of Patients Going for Cardiac Catheterization

NCT04044391 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2020-05-26

No results posted yet for this study

Summary

This is a multicenter, prospective trial to measure the test performance characteristics of the Magnetocardiography (MCG) CardioFlux cardiac diagnostic system in detecting clinically significant coronary artery obstruction in patients with symptoms of suspected acute coronary syndrome or who present with a failed stress test with the intention of treat with cardiac catheterization.

Conditions

  • Acute Coronary Syndrome
  • Coronary Artery Stenosis
  • Myocardial Ischemia

Interventions

DIAGNOSTIC_TEST

CardioFlux Magnetocardiograph

CardioFlux is a noninvasive diagnostic modality which can measure and image the heart's intrinsic magnetic field created by ion transit across cardiac cell membranes.

Sponsors & Collaborators

  • Genetesis Inc.

    lead INDUSTRY

Principal Investigators

  • Claire Pearson, M.D. · Ascension St, John Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2020-03-01
Completion
2020-05-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04044391 on ClinicalTrials.gov